Skip to main content

Table 2 Process and therapeutic indicators

From: Opposite trends in hospitalization and mortality after implementation of a chronic care model-based regional program for the management of patients with heart failure in primary care

 

CCM group (n = 1761)

Control group (n = 3522)

Creatinine and electrolyte tests

 Rate 2005-2009

55.8%

52.4%

 Rate 2010-2013

80.7%

65.3%

Beta-blocker therapy

 Rate 2005-2009

45.0%

43.0%

 Rate 2010-2013

65.1%

59.5%

ACE/ARBs therapy

 Rate 2005-2009

78.2%

76.7%

 Rate 2010-2013

81.0%

80.2%

  1. Rates of diagnostic and therapeutic indicators in the periods before and after chronic care model (CCM) project implementation among exposed and unexposed subjects. ARBs angiotensin receptor blockers, ACE angiotensin converting enzyme